Evidence map›Paper›PMID 25953183›Full record

ArticleGenome announcements2015

Complete Genome Sequence Analysis of Bacillus subtilis T30.

Shuang-Yong Xu, Matthew Boitano, Tyson A Clark, Tamas Vincze, Alexey Fomenkov, Sanjay Kumar, Priscilla Hiu-Mei Too, Danila Gonchar, Sergey K Degtyarev, Richard J Roberts

Abstract read
In one paragraph

Article in Genome announcements, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Characterization of BisI Homologs.Frontiers in microbiology · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shuang-Yong XuNew England Biolabs, Inc., Ipswich, Massachusetts, USA xus@neb.com roberts@neb.com.
Matthew BoitanoPacific Biosciences, Menlo Park, California, USA.
Tyson A ClarkPacific Biosciences, Menlo Park, California, USA.
Tamas VinczeNew England Biolabs, Inc., Ipswich, Massachusetts, USA.
Alexey FomenkovNew England Biolabs, Inc., Ipswich, Massachusetts, USA.
Sanjay KumarNew England Biolabs, Inc., Ipswich, Massachusetts, USA.
Priscilla Hiu-Mei TooNew England Biolabs, Inc., Ipswich, Massachusetts, USA.
Danila GoncharSibEnzyme Ltd., Novosibirsk, Russia.
Sergey K DegtyarevSibEnzyme Ltd., Novosibirsk, Russia.
Richard J RobertsNew England Biolabs, Inc., Ipswich, Massachusetts, USA xus@neb.com roberts@neb.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complete genome sequence of Bacillus subtilis T30 was determined by SMRT sequencing. The entire genome contains 4,138 predicted genes. The genome carries one intact prophage sequence (37.4 kb) similar to Bacillus phage SPBc2 and one incomplete prophage genome of 39.9 kb similar to Bacillus phage phi105.

Identifiers

PMID25953183
PMCPMC4424299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.